PATENT CLAIM ANALYSIS

Application Number: 16327643
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "233200"]

Abstract:
The present invention relates to the use of PIKfyve inhibitors to inhibit RANKL/RANK signaling and related compositions and methods.

Claim (Index 2):
The method of  claim 1 , wherein the subject in need is one diagnosed with a disease or disorder selected from the group consisting of hypercalcemia of malignancy, bone metastasis of the breast, bone metastasis of the prostate, cancer treatment induced bone loss, multiple myeloma, rheumatoid arthritis, psoriastic arthritis, osteoporosis, skeletal unloading or disuse, sporadic Paget's disease, juvenile Paget's disease, thyrosine excess and hyperthyroidism, periprothetic bone loss, periodontal disease, and cancer metastasis.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15524844', '15213829', '15113154', '14368080', '11705689']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8135826181291586
- 35 USC 102 Novelty (BERT): 0.5181365406377274
- Combined Prediction Score: 0.7840380103800154
- Mean Citation Score: 285.311098
- Max Citation Score: 322.0196200000001
- Similarity Product: 244.9635262557209

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test